Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung von Wolin, Edward M., MD

Volltext

PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors von Wolin, Edward M

Volltext

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors von Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Blumberg, Joëlle, Ruszniewski, Philippe

Volltext

Challenges in the Diagnosis and Management of Well‐Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations von Wolin, Edward M.

Volltext

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-control... von Pavel, Marianne E, Prof, Hainsworth, John D, Prof, Baudin, Eric, MD, Peeters, Marc, Prof, Hörsch, Dieter, Prof, Winkler, Robert E, MD, Klimovsky, Judith, MD, Lebwohl, David, MD, Jehl, Valentine, MSc, Wolin, Edward M, MD, Öberg, Kjell, Prof, Van Cutsem, Eric, Prof, Yao, James C, Dr

Volltext

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study von Yao, James C, Dr, Fazio, Nicola, MD, Singh, Simron, MD, Buzzoni, Roberto, MD, Carnaghi, Carlo, MD, Wolin, Edward, MD, Tomasek, Jiri, MD, Raderer, Markus, MD, Lahner, Harald, MD, Voi, Maurizio, MD, Pacaud, Lida Bubuteishvili, MD, Rouyrre, Nicolas, MSc, Sachs, Carolin, RN, Valle, Juan W, MD, Fave, Gianfranco Delle, MD, Van Cutsem, Eric, MD, Tesselaar, Margot, MD, Shimada, Yasuhiro, MD, Oh, Do-Youn, MD, Strosberg, Jonathan, MD, Kulke, Matthew H, MD, Pavel, Marianne E, MD

Volltext

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study von Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Gomez-Panzani, Edda, Ruszniewski, Philippe

Volltext

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: S... von Yao, James C, Guthrie, Katherine A, Moran, Cesar, Strosberg, Jonathan R, Kulke, Matthew H, Chan, Jennifer A, LoConte, Noelle, McWilliams, Robert R, Wolin, Edward M, Mattar, Bassam, McDonough, Shannon, Chen, Helen, Blanke, Charles D, Hochster, Howard S

Volltext

Everolimus for Advanced Pancreatic Neuroendocrine Tumors von Yao, James C, Shah, Manisha H, Ito, Tetsuhide, Bohas, Catherine Lombard, Wolin, Edward M, Van Cutsem, Eric, Hobday, Timothy J, Okusaka, Takuji, Capdevila, Jaume, de Vries, Elisabeth G.E, Tomassetti, Paola, Pavel, Marianne E, Hoosen, Sakina, Haas, Tomas, Lincy, Jeremie, Lebwohl, David, Öberg, Kjell

Volltext

Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review von Wolin, Edward M., Benson III, Al Bowen

Volltext

Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis von Fazio, Nicola, Buzzoni, Roberto, Delle Fave, Gianfranco, Tesselaar, Margot E., Wolin, Edward, Van Cutsem, Eric, Tomassetti, Paola, Strosberg, Jonathan, Voi, Maurizio, Bubuteishvili‐Pacaud, Lida, Ridolfi, Antonia, Herbst, Fabian, Tomasek, Jiri, Singh, Simron, Pavel, Marianne, Kulke, Matthew H., Valle, Juan W., Yao, James C.

Volltext

Consensus on biomarkers for neuroendocrine tumour disease von Oberg, Kjell, Prof, Modlin, Irvin M, Prof, De Herder, Wouter, Prof, Pavel, Marianne, Prof, Klimstra, David, Prof, Frilling, Andrea, Prof, Metz, David C, Prof, Heaney, Anthony, MD, Kwekkeboom, Dik, MD, Strosberg, Jonathan, MD, Meyer, Timothy, Prof, Moss, Steven F, Prof, Washington, Kay, Prof, Wolin, Edward, Prof, Liu, Eric, MD, Goldenring, James, Prof

Volltext

EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL von Vinik, Aaron I, Wolin, Edward M, Liyanage, Nilani, Gomez-Panzani, Edda, Fisher, George A

Volltext

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues von Wolin, Edward M, Jarzab, Barbara, Eriksson, Barbro, Walter, Thomas, Toumpanakis, Christos, Morse, Michael A, Tomassetti, Paola, Weber, Matthias M, Fogelman, David R, Ramage, John, Poon, Donald, Gadbaw, Brian, Li, Jiang, Pasieka, Janice L, Mahamat, Abakar, Swahn, Fredrik, Newell-Price, John, Mansoor, Wasat, Öberg, Kjell

Volltext

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study von Fazio, Nicola, Granberg, Dan, Grossman, Ashley, Saletan, Stephen, Klimovsky, Judith, Panneerselvam, Ashok, Wolin, Edward M

Volltext

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study von Caplin, Martyn E., Pavel, Marianne, Phan, Alexandria T., Ćwikła, Jarosław B., Sedláčková, Eva, Thanh, Xuan-Mai Truong, Wolin, Edward M., Ruszniewski, Philippe

Volltext

Multifocality in Small Bowel Neuroendocrine Tumors von Gangi, Alexandra, Siegel, Emily, Barmparas, Galinos, Lo, Simon, Jamil, Laith H., Hendifar, Andrew, Nissen, Nicholas N., Wolin, Edward M., Amersi, Farin

Volltext

Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States von Wolin, Edward M, Leyden, John, Goldstein, Grace, Kolarova, Teodora, Hollander, Ron, Warner, Richard R P

Volltext

Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and mai... von Wolin, Edward M

Volltext

The expanding role of somatostatin analogs in the management of neuroendocrine tumors von Wolin, Edward M

Volltext